Mark W. Youngblood
- Molecular Biology
- Epidemiology
- Genetics top 10%
- Neurology top 10%
- Cancer Research
- Co-authors
- Murat GünelKaya BilgüvarAdam M. SonabendRoger StuppChristopher D. GuzmanSensen ZhangMichael A. Q. MartinezLupeng Ye
- Topics
- Meningioma and schwannoma management (22 papers)Neurofibromatosis and Schwannoma Cases (12 papers)Pituitary Gland Disorders and Treatments (9 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Mark W. Youngblood
36 papers receiving 505 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 221
- Epidemiology 113
- Genetics 111
- Neurology 95
- Cancer Research 55
Countries citing papers authored by Mark W. Youngblood
This map shows the geographic impact of Mark W. Youngblood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Youngblood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Youngblood more than expected).
Fields of papers citing papers by Mark W. Youngblood
This network shows the impact of papers produced by Mark W. Youngblood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Youngblood. The network helps show where Mark W. Youngblood may publish in the future.
Co-authorship network of co-authors of Mark W. Youngblood
This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Youngblood. A scholar is included among the top collaborators of Mark W. Youngblood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Youngblood. Mark W. Youngblood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 14 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | 19 | |
| 12 | 2 | |
| 13 | 8 | |
| 14 | 15 | |
| 15 | 1 | |
| 16 | 29 | |
| 17 | 175 | |
| 18 | 18 | |
| 19 | 8 | |
| 20 | 38 |
About Mark W. Youngblood
Mark W. Youngblood is a scholar working on Neurology, Genetics and Epidemiology, having authored 39 papers that have together received 511 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (22 papers), Neurofibromatosis and Schwannoma Cases (12 papers) and Pituitary Gland Disorders and Treatments (9 papers). The work is most often cited by research in Genetics (111 citations), Neurology (95 citations) and Aging (10 citations). Mark W. Youngblood has collaborated with scholars based in United States, France and China. Frequent co-authors include Murat Günel, Kaya Bilgüvar, Adam M. Sonabend, Roger Stupp, Christopher D. Guzman, Sensen Zhang, Michael A. Q. Martinez, Lupeng Ye, Matthew B. Dong and Florian Schmidt. Their work appears in journals such as Nature Neuroscience, NeuroImage and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.